Chris Moxham is the Co-Founder, CEO, and CSO of Transcripta Bio, a biotech company accelerating drug discovery to improve lives globally. With over 25 years of experience, Chris earned his Ph.D. in Molecular and Cellular Pharmacology from Stony Brook University and spent two decades at Eli Lilly.
There, he played a key role in advancing more than 10 molecules into clinical trials across multiple therapeutic areas and modalities, including both small and large molecules. At Transcripta, he brings deep scientific and leadership expertise to rethinking how new medicines are discovered.
